A carregar...

Drotrecogin alfa (activated) ... a sad final fizzle to a roller-coaster party

Following the failure of PROWESS-SHOCK to demonstrate efficacy, Eli Lilly and Company withdrew drotrecogin alfa (activated) from the worldwide market. Drotrecogin was initially approved after the original trial, PROWESS, was stopped early for overwhelming efficacy. These events prompt consideration...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Angus, Derek C
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396243/
https://ncbi.nlm.nih.gov/pubmed/22309988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11152
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!